DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zofran (Ondansetron) - Pruritus - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pruritus (17)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zofran (Ondansetron) where reactions include pruritus. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Zofran side effects in male

Reported by a physician from France on 2012-08-24

Patient: male

Reactions: Burning Sensation, Pruritus, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Plitican
    Dosage: 100mg single dose
    Indication: Premedication
    Start date: 2012-08-07
    End date: 2012-08-07

Zofran
    Dosage: 8mg single dose
    Indication: Premedication
    Start date: 2012-08-07
    End date: 2012-08-07

Oxaliplatin
    Dosage: 160mg cyclic
    Indication: Colorectal Cancer
    Start date: 2012-08-07
    End date: 2012-08-07

Methylprednisolone
    Dosage: 40mg single dose
    Indication: Premedication
    Start date: 2012-08-07
    End date: 2012-08-07



Possible Zofran side effects in female

Reported by a physician from France on 2012-08-17

Patient: female

Reactions: Pruritus, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabthera
    Dosage: 650mg single dose
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2012-06-06
    End date: 2012-06-06

Zofran
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-27
    End date: 2012-06-03

Vincristine
    Dosage: 2mg see dosage text
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2012-05-27
    End date: 2012-06-03

Potassium Chloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-31
    End date: 2012-06-06

Other drugs received by patient: Augmentin '500'; Zolpidem Tartrate; Nplate



Possible Zofran side effects in female

Reported by a physician from France on 2012-08-15

Patient: female

Reactions: Fatigue, Pruritus, Nausea, Faecaloma, Herpes Zoster

Drug(s) suspected as cause:
Ebastine
    Indication: Pruritus

Loratadine
    Indication: Pruritus

Zantac
    Dosage: 50mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Zofran
    Dosage: 8mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Neulasta
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-27

Halaven
    Dosage: 1.58mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Solu-Medrol
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Other drugs received by patient: Cyclophosphamide; Fluorouracil; Methotrexate; Nexium; Bevacizumab; Doxorubicin HCL; Acebutolol



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: 65 year old female

Reactions: Weight Decreased, Blood Bilirubin Increased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Hypophagia, Alopecia, Dysuria, Feeling Abnormal, Asthenia, DRY Eye, Leukopenia

Drug(s) suspected as cause:
Victrelis
    Dosage: 800 mg; tid; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg; qd; po, 25 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Acetaminophen
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: qw; sc
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mcg; prn; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Rythmol
    Dosage: 325 mg; bid; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Aspirin
    Dosage: 81 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg; bid; po
    Administration route: Oral

Pradaxa
    Dosage: 150 mg; bid; po, 75 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Hydrochloride; Reglan; Metoclopramide



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: 65 year old female

Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Dysphagia, Blood Urine Present, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Feeling Abnormal, DRY Eye, Asthenia, Leukopenia

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: qw;sc
    Indication: Product Used FOR Unknown Indication

Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg;prn;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Pradaxa
    Dosage: 150 mg;bid;po 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Metoclopramide Hydrochloride; Reglan



Possible Zofran side effects in

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: , weighing 79.5 kg (174.9 pounds)

Reactions: Weight Decreased, Pruritus, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Photophobia, Product Quality Issue, Blood Urine Present, Dysphagia, Stomatitis, Nausea, Underdose, Poor Quality Drug Administered, Eye Pain, Dysgeusia, Blood Glucose Decreased, Bladder Spasm, Vaginal Inflammation, Alopecia, DRY Eye, Asthenia

Drug(s) suspected as cause:
Rythmol SR
    Indication: Product Used FOR Unknown Indication

Zofran
    Indication: Product Used FOR Unknown Indication



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03

Patient: 65 year old female

Reactions: Blood Bilirubin Increased, Weight Decreased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Stomatitis, Dysphagia, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Hypophagia, Dysuria, DRY Eye, Feeling Abnormal, Asthenia, Leukopenia

Drug(s) suspected as cause:
Pradaxa
    Dosage: 150 mg;bid;po 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg;prn;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tylenol (Caplet)
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: ;qw;sc
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Metoclopramide; Hydrochloride; Reglan



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03

Patient: 65 year old female

Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Asthenia, DRY Eye, Feeling Abnormal, Leukopenia

Drug(s) suspected as cause:
Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: ;qw;sc

Pradaxa
    Dosage: 150 mg;bid;po 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg;prn;po
    Administration route: Oral

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral

Tylenol (Caplet)
    Indication: Product Used FOR Unknown Indication

Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Hydrochloride; Metoclopramide; Reglan



Possible Zofran side effects in 48 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-01

Patient: 48 year old male

Reactions: Overdose, Pruritus, Rash, Epidermolysis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Taxotere
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-02-23
    End date: 2011-03-16

Zofran
    Administration route: Oral
    Start date: 2010-10-06
    End date: 2011-03-20

Emend
    Administration route: Oral
    Start date: 2011-03-16
    End date: 2011-03-18

Prednisolone
    Administration route: Oral
    Start date: 2010-10-06
    End date: 2011-03-20



Possible Zofran side effects in female

Reported by a individual with unspecified qualification from United States on 2012-01-18

Patient: female

Reactions: Tooth Loss, Abdominal Pain, Pruritus, Eczema, Oral Discomfort, Rheumatoid Arthritis, DRY Mouth, Oedema Peripheral, Ileitis, Vertebral Foraminal Stenosis, Back Pain, Melanosis Coli, Osteopenia, Bursitis, Respiratory Tract Congestion, Diverticulum, Increased Tendency To Bruise, Vision Blurred, Left Atrial Dilatation, Abscess, Pyoderma Gangrenosum, Fall, Dermatitis Contact, Intertrigo, Vitreous Floaters, Conjunctivochalasis, Obesity, Rotator Cuff Syndrome, Dyspnoea, Cataract, Excoriation, Joint Dislocation, Varicose Ulceration, Ulnar Neuritis, Syncope, Visual Impairment, Loose Tooth, Gait Disturbance, DRY Eye, Urinary Incontinence, Dementia, Flatulence, Lumbar Spinal Stenosis, Dyspepsia, Electrocardiogram T Wave Abnormal, Ingrowing Nail, Resorption Bone Increased, Radiculopathy, General Physical Health Deterioration, Venous Insufficiency, Hypoaesthesia, Ankle Fracture, Osteonecrosis, Wound Infection Pseudomonas, Joint Swelling, Insomnia, Otitis Media, Colitis, Glaucoma, Pain, Constipation, Gastritis, Fatigue, Bone Loss, Road Traffic Accident, Skin Ulcer, Corneal Dystrophy, Glare, Microangiopathy, Gastrooesophageal Reflux Disease, Pain in JAW, Abdominal Pain Lower, Vulvovaginal Mycotic Infection, Hyponatraemia, Cystitis, Varicose Vein, Facial Pain, Mucosal Inflammation, Anxiety, Diarrhoea, Osteonecrosis of JAW, Deep Vein Thrombosis, Inflammatory Bowel Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zometa
    Dosage: 4 mg, daily
    Indication: Osteoporosis
    Start date: 2005-07-12
    End date: 2006-07-06

Zometa
    Dosage: 3.3 mg, unk

Zofran
    Dosage: 4 mg/2ml, q8h

Other drugs received by patient: Dapsone; Keflex; Vicodin; Meperidine HCL; Imodium; Diovan; Miconazole Nitrate; Clonidine Hydrochloride; Protonix; Omeprazole; Clindamycin; Meclizine; Toradol; Ciprofloxacin; Docusate; Arimidex; Effexor; Gabapentin; Ambien; Citalopram Hydrochloride; Univasc; Triamterene and Hydrochlorothiazide; Furosemide; Venlafaxine; Depo-Medrol; Vytone; Chlordiazepoxide W / Clidinium Bromide; Mobic; Phenergan; Clinoril; Quinine Sulfate; Diphenhydramine HCL; Mytussin DAC; Cephalexin; Norvasc; Diphenoxylate HCL and Atropine Sulfate; Orphenadrine Citrate; Aricept; Acetaminophen and Hydrocodone Bitartrate; Prochlorperazine; Atenolol; Fluoxetine; Spironolactone; Sulindac; Hydrocortisone; Mirapex; Benicar; Compazine; Ancef; Percocet; Naproxen; Sucralfate; Ultram; Desoximetasone; Metoprolol; Orphenadrine Citrate; Tramadol HCL; Nexium; Amoxicillin and Clavulanate Potassium; Lisinopril; Pepcid; Cyclobenzaprine HCL; Miralax; Armodafinil



Possible Zofran side effects in female

Reported by a physician from France on 2012-01-13

Patient: female

Reactions: Pruritus, Rash Erythematous

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Indication: Myelodysplastic Syndrome
    Start date: 2011-10-10

Zofran
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2011-10-10

Other drugs received by patient: Ezetimibe; Metformin HCL; Bisoprolol Fumarate; Diclofenac; Valsartan; Esidrix



Possible Zofran side effects in 44 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-29

Patient: 44 year old male

Reactions: Pruritus, Rash

Drug(s) suspected as cause:
Rocephin
    Start date: 2011-11-29
    End date: 2011-12-09

Zofran
    Start date: 2011-11-29
    End date: 2011-12-09

Zovirax
    Start date: 2011-11-29
    End date: 2011-12-09

Pantoprazole Sodium
    Start date: 2011-11-29
    End date: 2011-12-09

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-29
    End date: 2011-12-03

Lamivudine
    Start date: 2011-11-29
    End date: 2011-12-09

Nystatin
    Start date: 2011-11-29
    End date: 2011-12-09

Cepacaine
    Start date: 2011-11-29
    End date: 2011-12-08

Dipyrone TAB
    Start date: 2011-11-29
    End date: 2011-12-09

Fluconazole
    Start date: 2011-12-02
    End date: 2011-12-09

Tramadol Hydrochloride
    Start date: 2011-11-29
    End date: 2011-12-09

Clindamycin
    Start date: 2011-11-29
    End date: 2011-12-09



Possible Zofran side effects in 48 year old male

Reported by a physician from France on 2011-12-28

Patient: 48 year old male

Reactions: Pruritus, Toxic Epidermal Necrolysis, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zofran
    Administration route: Oral
    Indication: Premedication
    Start date: 2010-10-06
    End date: 2011-03-20

Emend
    Administration route: Oral
    Indication: Premedication
    Start date: 2011-03-16
    End date: 2011-03-18

Taxotere
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-02-23
    End date: 2011-03-16

Prednisolone
    Indication: Premedication
    Start date: 2010-10-06
    End date: 2011-03-20



Possible Zofran side effects in 65 year old female

Reported by a individual with unspecified qualification from United States on 2011-12-16

Patient: 65 year old female

Reactions: Weight Decreased, Blood Bilirubin Increased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Dysuria, Alopecia, Hypophagia, Asthenia, Feeling Abnormal, DRY Eye, Leukopenia

Drug(s) suspected as cause:
Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral

Pradaxa
    Dosage: 150 mg;bid;po, 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg; pan; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: ;qw;sc

Acetaminophen
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po, 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Metoclopramide HCL; Reglan



Possible Zofran side effects in 13 year old male

Reported by a physician from United States on 2011-10-20

Patient: 13 year old male, weighing 39.6 kg (87.1 pounds)

Reactions: Anxiety, Abdominal Pain, Pruritus, Chills, Anger

Drug(s) suspected as cause:
PEG-Asparaginase
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-09-08

Benadryl
    Indication: Product Used FOR Unknown Indication

Ranitidine
    Indication: Product Used FOR Unknown Indication

Bactrim
    Indication: Product Used FOR Unknown Indication

Velcade
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-09-08

Zofran
    Indication: Product Used FOR Unknown Indication

Prednisone
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-09-08

Doxorubicin HCL
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-09-08

Vincristine
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-09-08

Other drugs received by patient: Ativan; Methotrexate; Hydrocortisone; Cytarabine; Scopolamine



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-11

Patient: 65 year old female, weighing 79.4 kg (174.6 pounds)

Reactions: Blood Bilirubin Increased, Weight Decreased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Stomatitis, Dysphagia, Blood Urine Present, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Hypophagia, Alopecia, Dysuria, Feeling Abnormal, DRY Eye, Asthenia, Leukopenia

Drug(s) suspected as cause:
Cozaar
    Dosage: 50 mg daily
    Indication: Hypertension

Aspirin
    Dosage: 81 mg daily, oral
    Administration route: Oral

Peginterferon Alfa-2A
    Dosage: 180 microgram/0.5 ml,1 each friday night ; 180 microgram/ml weekly, subcutaneous
    Indication: Hepatitis C
    Start date: 2005-09-01
    End date: 2006-02-01

Peginterferon Alfa-2A
    Dosage: 180 microgram/0.5 ml,1 each friday night ; 180 microgram/ml weekly, subcutaneous
    Indication: Hepatitis C
    Start date: 2011-07-29

Victrelis
    Dosage: 200 mg (four thrice daily),oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-26

Pradaxa
    Dosage: 150 mg am and pm, oral ; 75mg daily, oral
    Administration route: Oral
    Indication: Anticoagulant Therapy

Toprol-XL
    Dosage: 50 mg once daily,oral ; 25mg daily, oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-01-01

Acetaminophen

Nuvigil
    Dosage: 50mg daily, oral
    Administration route: Oral

Ribavirin
    Dosage: 600 mg, one in am and pm ; 600mg am and 400mg pm, oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-23

Ribavirin
    Dosage: 600 mg, one in am and pm ; 600mg am and 400mg pm, oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2005-09-01
    End date: 2006-02-01

Ribavirin
    Dosage: 600 mg, one in am and pm ; 600mg am and 400mg pm, oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-29

Zofran
    Dosage: 8 mg (one every 12 hrs as needed), oral
    Administration route: Oral
    Indication: Nausea
    Start date: 2011-08-26

Rythmol SR (Propaphenone Hcl)
    Dosage: 325 mg (am and pm each),oral
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2008-01-01

Other drugs received by patient: Calcium Carbonate; Metoclopramide Hydrochloride; Fish OIL with Omega3 Fatty Acids; Multi-Vitamins; Calcium Plus Vitamin D; Reglan



Possible Zofran side effects in 13 year old male

Reported by a physician from United States on 2011-10-10

Patient: 13 year old male, weighing 39.6 kg (87.1 pounds)

Reactions: Anxiety, Confusional State, Akathisia, Pruritus, Pain, Chills, Anger, Memory Impairment, Paraesthesia

Drug(s) suspected as cause:
Methotrexate
    Indication: Precursor B-Lymphoblastic Lymphoma
    Start date: 2011-09-08

Pegaspargase
    Indication: Precursor B-Lymphoblastic Lymphoma
    Start date: 2011-09-08

Zofran
    Indication: Product Used FOR Unknown Indication

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: Precursor B-Lymphoblastic Lymphoma
    Start date: 2011-09-08

Bactrim
    Indication: Product Used FOR Unknown Indication

Ranitidine
    Indication: Product Used FOR Unknown Indication

Prednisone
    Dosage: 20mgm2 cyclic
    Administration route: Oral
    Indication: Precursor B-Lymphoblastic Lymphoma
    Start date: 2011-09-08

Benadryl
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Indication: Precursor B-Lymphoblastic Lymphoma

Hydrocortisone
    Indication: Precursor B-Lymphoblastic Lymphoma
    Start date: 2011-09-08

Ativan
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3mgm2 cyclic
    Indication: Precursor B-Lymphoblastic Lymphoma
    Start date: 2011-09-08

Doxorubicin HCL
    Dosage: 60mgm2 cyclic
    Indication: Precursor B-Lymphoblastic Lymphoma
    Start date: 2011-09-08

Scopolamine
    Indication: Product Used FOR Unknown Indication

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014